⌘K
t
Haleon plc: Total Voting Rights and Capital
02 January 2026: As at 31 December 2025 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,952,353,648 ordinary shares of £0.01 each, of which 45,745,646 are held as treasury shares.
Therefore, the number of ordinary shares with voting rights is 8,906,608,002 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notifiable interests in Haleon may be sent to: company.secretary@haleon.com
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.
Haleon plc announced its total voting rights and capital as at 31 December 2025. The company had 8,952,353,648 ordinary shares of £0.01 each issued, of which 45,745,646 were held as treasury shares. Therefore, the total number of ordinary shares with voting rights is 8,906,608,002.
| Date | 2 Jan 2026 |
| Time | 07:00:05 |
| Category | Capital structure |
| ID | 3626N |